You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 19, 2025

Suppliers and packagers for CLOBETASOL PROPIONATE (EMOLLIENT)


✉ Email this page to a colleague

« Back to Dashboard


CLOBETASOL PROPIONATE (EMOLLIENT)

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Beach Prods CLOBETASOL PROPIONATE (EMOLLIENT) clobetasol propionate CREAM;TOPICAL 209411 ANDA The J. Molner Company LLC 83148-064-15 1 TUBE in 1 CARTON (83148-064-15) / 15 g in 1 TUBE 2025-09-29
Beach Prods CLOBETASOL PROPIONATE (EMOLLIENT) clobetasol propionate CREAM;TOPICAL 209411 ANDA The J. Molner Company LLC 83148-064-30 1 TUBE in 1 CARTON (83148-064-30) / 30 g in 1 TUBE 2025-09-29
Beach Prods CLOBETASOL PROPIONATE (EMOLLIENT) clobetasol propionate CREAM;TOPICAL 209411 ANDA The J. Molner Company LLC 83148-064-60 1 TUBE in 1 CARTON (83148-064-60) / 60 g in 1 TUBE 2025-09-29
Fougera Pharms CLOBETASOL PROPIONATE (EMOLLIENT) clobetasol propionate CREAM;TOPICAL 075430 ANDA E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. 0168-0301-15 1 TUBE in 1 CARTON (0168-0301-15) / 15 g in 1 TUBE 1999-05-26
Fougera Pharms CLOBETASOL PROPIONATE (EMOLLIENT) clobetasol propionate CREAM;TOPICAL 075430 ANDA E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. 0168-0301-30 1 TUBE in 1 CARTON (0168-0301-30) / 30 g in 1 TUBE 1999-05-26
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for the Pharmaceutical Drug: Clobetasol Propionate (Emollient)

Last updated: August 2, 2025


Introduction

Clobetasol Propionate, a potent topical corticosteroid, is widely prescribed for inflammatory skin conditions such as eczema, psoriasis, and dermatitis. While primarily classified as an anti-inflammatory agent, formulations often include emollients to enhance skin hydration and improve drug delivery. As a critical component, sourcing reliable suppliers for both the active pharmaceutical ingredient (API) and formulation excipients—including emollients—is essential for pharmaceutical manufacturers.

This article provides a comprehensive overview of suppliers specializing in Clobetasol Propionate and associated emollients used in its formulations. It offers insights into global API manufacturers, excipient suppliers, and key considerations for procurement to support drug development, manufacturing, and regulatory compliance.


Overview of Clobetasol Propionate Suppliers

API Manufacturers

Clobetasol Propionate is synthesized by several global pharmaceutical and chemical companies, some of which are integrated with excipient and formulation production.

1. Hainan Yiken Pharmaceutical Co., Ltd. (China)
A prominent API producer specializing in corticosteroids, including Clobetasol Propionate. The company emphasizes quality compliance with international standards such as USP, EP, and JP. Their production capabilities cater to both domestic Chinese and international markets, with a focus on pharmaceutical-grade APIs suitable for topical formulations.

2. Dr. Reddy’s Laboratories (India)
A leading global pharmaceutical manufacturer, Dr. Reddy’s supplies high-quality Clobetasol Propionate APIs to the dermatological segment. Their production adheres to stringent quality control norms aligned with global regulatory standards, ensuring consistent supply.

3. G&W Laboratories, Inc. (USA)
An established manufacturer of corticosteroid APIs, G&W Laboratories offers Clobetasol Propionate with verified batch-to-batch consistency, complying with FDA regulations. Their US-based operations facilitate rapid distribution within North America.

4. Duolambda Biotech (India)
Specializes in corticosteroid APIs, offering Clobetasol Propionate with a focus on quality, cost competitiveness, and reliable supply for both domestic and international clients.

5. Sun Pharmaceutical Industries (India)
Sun Pharma manufactures various corticosteroids, including Clobetasol Propionate, with a robust supply chain catering to global markets, emphasizing GMP compliance and quality assurance.


Innovative and Proprietary API Suppliers

Beyond traditional manufacturers, some biotech firms and smaller API producers are developing novel synthetic routes or biosynthetic pathways to produce Clobetasol Propionate, aiming for higher purity and environmentally sustainable production.

Examples include:

  • BASF (Germany): Although primarily known for chemical intermediates, BASF collaborates with pharmaceutical firms to supply key intermediates involved in corticosteroid synthesis.

  • Viatris Inc. (USA): Offers a portfolio of corticosteroid APIs, including Clobetasol Propionate, emphasizing regulatory compliance and supply security.


Excipients & Emollients Suppliers for Clobetasol Propionate Formulations

While Clobetasol Propionate acts as the active ingredient, its topical formulations often contain emollients and excipients to optimize efficacy and patient compliance. The choice of emollients can impact drug absorption and tolerability.

1. BASF (Germany)
A leading supplier of pharmaceutical excipients, BASF offers emollients such as silicones (e.g., dimethicone) and fatty acids (e.g., stearic acid) used in corticosteroid formulations. Their products are compliant with pharmacopeial standards.

2. Evonik Industries (Germany)
Specializes in silicone-based emollients and skin-conditioning agents. Evonik's cyclopentasiloxane and dimethicone are frequently used in topical corticosteroid products for their spreading and occlusive properties.

3. Croda International Plc (UK)
Supplies a broad range of emollients including stearates, hydrocarbons, and ester-based lipids, which enhance skin hydration and drug penetrability.

4. Solvay (Belgium)
Provides pharmaceutically acceptable emollients like glycerides and esters used in corticosteroid creams and ointments, ensuring compatibility with active ingredients.

5. Localized and Regional Suppliers
Depending on manufacturing location, regional suppliers may offer cost-effective emollients compliant with local regulations. For example, in India, suppliers like Makwell and Nocil provide suitable excipients suitable for topical formulations.


Sources and Considerations in Supplier Selection

Selecting suppliers for Clobetasol Propionate and emollients involves compliance with stringent quality standards, regulatory approvals, and supply chain reliability.

Key considerations include:

  • Regulatory compliance: Suppliers must meet cGMP requirements and have relevant certificates such as FDA, EMA, or local regulatory clearances.
  • Quality assurance: Batch consistency, purity levels, and absence of impurities are crucial—particularly for corticosteroid APIs due to strict safety standards.
  • Supply security: Given market demand fluctuations, reliable inventory management and contingency plans are vital.
  • Cost competitiveness: Balancing affordability with quality is essential, especially in markets with price sensitivity.

Emerging Trends and Future Outlook

The pharmaceutical industry is increasingly focused on sustainable practices, with suppliers adopting greener manufacturing processes for corticosteroid APIs and emollients. Biosynthetic routes for APIs like Clobetasol Propionate are under development, promising higher purity and reduced environmental impact.

Additionally, customization of emollients tailored to specific formulations is gaining traction, with suppliers investing in R&D to develop products that improve drug stability, skin tolerability, and patient adherence.


Conclusion

The global supply chain for Clobetasol Propionate encompasses a diverse set of manufacturers and excipient providers. Proven API suppliers include firms from China, India, and the United States with established regulatory compliance, ensuring a stable supply for pharmaceutical companies. Complementary emollient suppliers from Europe and regional markets support formulators aiming for high-quality, patient-friendly topical products.

Effective procurement hinges on thorough qualification processes, ongoing quality monitoring, and strategic diversification of supplier relationships. Emphasizing compliance, reliability, and sustainability will position companies to navigate the complex landscape of corticosteroid formulation manufacturing effectively.


Key Takeaways

  • API sourcing for Clobetasol Propionate predominantly involves manufacturers in China (Hainan Yiken), India (Dr. Reddy's, Sun Pharma), and the U.S. (G&W Laboratories).
  • Emollient suppliers such as BASF, Evonik, and Croda provide critical excipients used in topical corticosteroid formulations, enhancing drug delivery and patient tolerability.
  • Regulatory compliance remains paramount in supplier qualification, with GMP certifications, batch consistency, and impurity profiles serving as core criteria.
  • Supply chain resilience demands diversified sourcing strategies to mitigate risks associated with geopolitical, regulatory, or manufacturing disruptions.
  • Innovation and sustainability trends are shaping future supply practices, with biosynthetic APIs and eco-friendly excipients gaining prominence.

FAQs

1. Are there regional differences in Clobetasol Propionate suppliers?
Yes. Suppliers vary by region, with Chinese companies dominating in Asia, Indian firms providing cost-effective options, and American companies focusing on compliance and advanced formulations.

2. What regulatory standards should suppliers meet for pharmaceutical-grade Clobetasol Propionate?
Suppliers must adhere to cGMP, with APIs and excipients meeting standards such as USP, EP, JP, or relevant local regulations (e.g., Chinese GMP certifications).

3. Can I source specialty emollients for unique formulations?
Yes. Many suppliers offer customizable emollient blends tailored to specific formulation needs, with technical support to ensure compatibility and stability.

4. How do I verify supplier quality?
Through audit inspections, review of regulatory certifications, batch testing data, and supplier quality agreements. Ongoing quality monitoring ensures maintained standards.

5. What future developments could impact Clobetasol Propionate supply?
Advancements in biosynthesis, green manufacturing, and formulation innovations could influence supply chain dynamics, potentially improving purity, reducing costs, and supporting sustainable practices.


Sources:

  1. [1] “Global API Manufacturers of Corticosteroids,” Pharmaceutical Technology Reports, 2022.
  2. [2] BASF Product Portfolio, https://www.basf.com.
  3. [3] Evonik Industries, “Pharmaceutical Emollients,” 2023.
  4. [4] Croda International, “Skin Conditioning Agents,” 2022.
  5. [5] FDA and EMA guidelines on corticosteroid API manufacturing standards.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.